Imbio PHA (4.0.0) vs Viz AAA

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio (a subsidiary of 4DMedical)
VS
by Viz.ai

AI Verdict

These two AI-powered tools are adjacent competitors, both leveraging medical imaging for cardiovascular insights. Imbio PHA focuses on the automated measurement of cardiac structures from CTPA scans to assess pulmonary embolism and hypertension, while Viz AAA specializes in the detection and triage of suspected Abdominal Aortic Aneurysm from CTA scans to accelerate care coordination.

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA (4.0.0) if your primary need is a detailed, quantitative assessment of cardiac structures from CT pulmonary angiogram (CTPA) scans to evaluate for right ventricular dilation, pulmonary embolism, or hypertension. This tool excels at providing automated measurements of RV/LV and PA/Ao ratios, generating annotated DICOM images and comprehensive PDF reports for in-depth analysis and diagnosis.

View Imbio PHA (4.0.0) →

Choose Viz AAA if…

Choose Viz AAA if your priority is the rapid, AI-powered detection and immediate triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, coupled with accelerated care coordination. This solution is ideal for emergency settings where timely alerts, prioritization of cases, and seamless communication among multidisciplinary care teams are critical to improve patient outcomes.

View Viz AAA →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Imbio PHA (4.0.0) Viz AAA
Pricing Unknown Enterprise (hospital/health system)
Deployment Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). Cloud-based, integrates with PACS and EHR systems.
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Imbio PHA (4.0.0) Viz AAA
Product Name Imbio PHA (4.0.0) Viz AAA
Company Imbio Viz.ai
Primary Use Case Automated measurement of cardiac structures from CTPA scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination.
Target Specialties Cardiology, Pulmonology, Radiology Emergency Medicine, Radiology, Vascular Surgery
Key Outputs/Alerts Generates annotated DICOM images, Provides summary reports in PDF format. Real-time alerts to care teams, Mobile access to high-fidelity imaging and patient information, HIPAA-compliant communication platform for multidisciplinary teams.

Videos

Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Viz AAA.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio PHA (4.0.0) is designed to measure cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension. Viz AAA is an AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans.
Imbio PHA (4.0.0) specifically utilizes CT pulmonary angiogram (CTPA) scans for its analysis. Viz AAA processes CT angiography (CTA) scans of the abdomen to detect suspected AAA.
Imbio PHA (4.0.0) provides automated measurements of right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios, generating annotated DICOM images and PDF summary reports. Viz AAA offers AI-powered automatic detection of suspected AAA, automated triage and prioritization of cases, real-time alerts to care teams, and a HIPAA-compliant communication platform.
Imbio PHA (4.0.0) is primarily aimed at Cardiology, Pulmonology, and Radiology specialties. Viz AAA targets Emergency Medicine, Radiology, and Vascular Surgery.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.